Lack of effect of doxycycline on disease activity and joint damage in patients with rheumatoid arthritis. A double blind, placebo controlled trial

Journal of Rheumatology

Volumn 28, Issue 9, 2001, Pages 1967-1974

  Van der Laan, W ^a   Molenaar, E ^a   Ronday, K ^a   Verheijen, J ^a   Breedveld, F ^a   Greenwald, R ^a   Dijkmans, B ^a   Tekoppele, J ^a  

^a TNO   (Netherlands)

Author keywords

Doxycycline; Pyridinolines; Rheumatoid arthritis

Indexed keywords

DEOXYPYRIDINOLINE; DOXYCYCLINE; PLACEBO; PYRIDINOLINE;

ADULT; AGED; ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE ACTIVITY; DOUBLE BLIND PROCEDURE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOOT RADIOGRAPHY; HAND RADIOGRAPHY; HUMAN; JOINT DESTRUCTION; JOINT STIFFNESS; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ARTHRITIS, RHEUMATOID; CHI-SQUARE DISTRIBUTION; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DOXYCYCLINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; REFERENCE VALUES; SEVERITY OF ILLNESS INDEX; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0034861797     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Long-term course and outcome of functional capacity in rheumatoid arthritis: The effect of disease activity and radiologic damage over time
2. Etiology and pathogenesis of rheumatoid arthritis
3. Tranexamic acid, an inhibitor of plasminogen activation, reduces urinary collagen cross-link excretion in both experimental and rheumatoid arthritis
4. Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of a cell surface-targeted plasmin inhibitor
5. Expression of stromelysin 3 and tissue inhibitors of matrix metalloproteinases. TIMP-1 and TIMP-2, in rheumatoid arthritis
6. Immunolocalisation studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis
7. Transin/stromelysin expression in rheumatoid synovium. A transformation-associated metalloproteinase secreted by phenotypically invasive synoviocytes
8. Determination of interstitial collagenase (MMP-1) in patients with rheumatoid arthritis
9. Serum levels of matrix metalloproteinase-3 in relation to the development of radiological damage in patients with early rheumatoid arthritis
10. Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycycline
11. Tetracyclines suppress matrix metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen, ameliorate bone damage
12. In vivo inhibition of human neutrophil collagenase (MMP-8) activity during long-term combination therapy of doxycycline and non-steroidal anti-inflammatory drugs in acute reactive arthritis
13. Tetracyclines inhibit human synovial collagenase in vivo and in vitro
14. Oral administration of doxycycline reduces collagenase and gelatinase activities in extracts of human osteoarthritic cartilage
15. Minocycline in active rheumatoid arthritis. A placebo-controlled trial
16. Treatment of early rheumatoid arthritis with minocycline or placebo: Results of a randomized, double-blind, placebo-controlled trial
17. Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial
18. Radiographic results from the minocycline in rheumatoid arthritis trial
19. Minocycline related lupus
20. Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome
21. Low dose doxycycline inhibits pyridinoline excretion in selected patients with rheumatoid arthritis
22. Anti-collagenolytic mechanism of action of doxycycline treatment in rheumatoid arthritis
23. Elevation of urinary pyridinoline in adjuvant arthritic rats and its inhibition by doxycycline
24. Urinary hydroxypyridinium cross-links of collagen in rheumatoid arthritis. Relation to disease activity and effects of methylprednisolone
25. Urinary excretion of the hydroxypyridinium cross links of collagen in patients with rheumatoid arthritis
26. Levels of markers of bone resorption are moderately increased in patients with inactive rheumatoid arthritis
27. Urinary excretion of pyridinium crosslinks of collagen correlated with joint damage in arthritis
28. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
29. Therapy for rheumatoid arthritis: Combinations of disease-modifying drugs and new paradigms of treatment
30. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis
31. Sensitive fluorimetric quantitation of pyridinium and pentosidine crosslinks in biological samples in a single high-performance liquid chromatographic run
32. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis
33. Collagenase-2 and -3 are inhibited by doxycycline in the chronically inflamed lung in bronchiectasis
34. Proteinases and connective tissue breakdown
35. Pilot clinical trial of intravenous doxycycline versus placebo for rheumatoid arthritis
36. Antimicrobial therapy for rheumatoid arthritis
37. A novel mechanism of action of tetracyclines: Effects on nitric oxide synthases
38. Doxycycline induces Fas/Fas ligand-mediated apoptosis in Jurkat T lymphocytes
39. The effects of intravenous doxycycline therapy for rheumatoid arthritis: A randomized, double-blind, placebo-controlled trial
40. Clinical pharmacokinetics of doxycycline and minocycline
41. Antimicrobial agents: Tetracyclines, chloramphenicol, erythromycin, and miscellaneous antibacterial agents
42. Neuroimmunomodulation via limbic structures - The neuroanatomy of psychoimmunology
43. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms
44. A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis
45. Low-dose doxycycline therapy: Effect on gingival and crevicular fluid collagenase activity in humans
46. In vitro sensitivity of the three mammalian collagenases to tetracycline inhibition: Relationship to bone and cartilage degradation
47. Doxycycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis gingiva
48. Effects of tetracyclines on neutrophil, gingival, and salivary collagenases. A functional and western-blot assessment with special reference to their cellular sources in periodontal diseases
49. Specificity of inhibition of matrix metalloproteinase activity by doxycycline: Relationship to structure of the enzyme
50. Inhibition of matrix metalloproteinases by tetracyclines